RETIREMENT BENEFIT AGREEMENTRetirement Benefit Agreement • February 9th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
This Retirement Benefit Agreement (the “Agreement”) is entered into as of the 31st day of December, 2004 (the “Effective Date”) by and between:
AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 9th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Robert J. Coury (the “Executive”), is made as of December 2, 2004.
AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 9th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Louis J. DeBone (the “Executive”), is made as of December 2, 2004.
AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 9th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Stuart A. Williams (the “Executive”), is made as of December 2, 2004.
AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 9th, 2005 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and John P. O’Donnell (the “Executive”), is made as of December 2, 2004.
